Gastric-Type Expression Signature in Hepatocellular Carcinoma
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25126588 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Rita Szodorai und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, George Emil Palade University of Medicine, Pharmacy, Science and Technology, 540139 Targu Mures, Romania. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Vimentin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
It is known that V-set and immunoglobulin domain containing 1 (VSIG1) is a cell–cell adhesion molecule that can serve as an indicator of better survival in patients with gastric cancer. Its interaction with cytoplasmic thyroid transcription factor 1 (TTF-1) has been hypothesized to characterize gastric-type HCC, but its clinical importance is far from understood. As VSIG1 has also been supposed to be involved in the epithelial–mesenchymal transition (EMT) phenomenon, we checked for the first time in the literature the supposed interaction between VSIG1, TTF-1, and Vimentin (VIM) in HCCs. Immunohistochemical (IHC) stains were performed on 217 paraffin-embedded tissue samples that included tumor cells and normal hepatocytes, which served as positive internal controls. VSIG1 positivity was seen in 113 cases (52.07%). In 71 out of 217 HCCs (32.71%), simultaneous positivity for VSIG1 and TTF-1 was seen, being more specific for G1/G2 carcinomas with a trabecular architecture and a longer OS (p = 0.004). A negative association with VIM was revealed (p < 0.0001). Scirrhous-type HCC proved negative for all three examined markers. The present paper validates the hypothesis of the existence of a gastric-type HCC, which shows a glandular-like architecture and is characterized by double positivity for VSIG1 and TTF-1, vimentin negativity, and a significant OS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, George Emil Palade University of Medicine, Pharmacy, Science and Technology, 540139 Targu Mures, Romania.
- Department of Pathology, Clinical County Emergency Hospital Targu Mures, 540140 Targu Mures, Romania.
- Department of Pathology and Experimental Cancer Research, Faculty of Medicine, Semmelweis University, 1085 Budapest, Hungary.
- Research Center of Oncopathology and Translational Research (CCOMT), 540139 Targu Mures, Romania.
- Romanian Academy of Medical Sciences, 030167 Bucharest, Romania.
ORCID-Profile: Laura Banias, Ilona Kovalszky, Simona Gurzu
Zitieren
APA
Szodorai, R., Banias, L., Kovalszky, I., Dezső, K., Kovács, Z., & Gurzu, S. (2024). Gastric-Type Expression Signature in Hepatocellular Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25126588
Vancouver
Szodorai R, Banias L, Kovalszky I, Dezső K, Kovács Z, Gurzu S. Gastric-Type Expression Signature in Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25126588
BibTeX
@article{Szodorai2024,
author = {Szodorai, Rita and Banias, Laura and Kovalszky, Ilona and Dezső, Katalin and Kovács, Zsolt and Gurzu, Simona},
title = {Gastric-Type Expression Signature in Hepatocellular Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25126588}
}
EUVIMED